Treace Medical Concepts, Inc. TMCI · Stock Open Treace Medical Concepts, Inc. in new tab
Treace Medical Concepts, Inc. Analysis (TMCI)
Is Treace Medical Concepts, Inc. a good investment? Treace Medical Concepts, Inc. (TMCI) is currently trading at 8.56 USD. Market analysts have a consensus price target of 7.50 USD. This suggests the asset is currently trading above analyst expectations.
Earnings Schedule: Treace Medical Concepts, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -0.75.
Investor FAQ
Does Treace Medical Concepts, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Treace Medical Concepts, Inc.?
Treace Medical Concepts, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -0.99.
Company Profile
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Community Discussion